Latest Financials News

FirstWave Cloud Technology reports a cash-flow positive quarter with a $2.85 million capital raise and advances its AI-powered compliance product, targeting a commercial release by November.

Citigold Corporation continues its efforts to restart the high-grade Charters Towers Gold Project, focusing on exploration, mine design, and securing funding despite a significant annual loss.

Terra Critical Minerals (ASX, T92) broadens its critical minerals portfolio with new US initiatives and promising exploration in New South Wales and Canada. The company also pursues a US OTC listing to tap North American capital.

Vulcan Steel reported a sharp profit decline in FY25 amid tough market conditions but strengthened its balance sheet and expanded into roofing with a major acquisition. Leadership changes set the stage for renewed growth.

HALO Technologies reports a 17% rise in quarterly revenue, driven by a surge in brokerage income and a strategic launch of Managed Funds in Australia, supported by a recent $3.9 million rights issue.

Pure Hydrogen Corporation reported strong commercial momentum in the September 2025 quarter, securing multiple hydrogen vehicle orders across Australia and the US, expanding international distribution, and raising fresh capital to fuel growth.

Emperor Energy has secured a significant resource upgrade for its Judith Gas Field and raised $3.7 million to progress the Judith-2 appraisal well, targeting commercial gas supply in a tightening East Coast market.

Blue Energy has been granted a critical petroleum lease in Queensland and completed a $5.8 million capital raise, positioning itself to meet rising gas demand aligned with the Queensland Government’s new Energy Roadmap.

Surefire Resources reports robust drilling results at its Yidby Gold Project alongside promising assays from its Victory Bore critical minerals deposit, supported by a $1.54 million capital raise.

HITIQ Ltd has secured a landmark order for its PROTEQT™ mouthguards at the Winter Olympics and launched in the UK consumer market, while advancing global validation and raising over A$2 million in capital.

International Graphite Limited has made significant strides in its global graphite strategy, signing a German joint venture and securing $3 million in US institutional funding to support its expanding mine-to-market operations.

Clarity Pharmaceuticals has bolstered its financial position with a $203 million institutional placement and reported positive Phase II trial results for its lead prostate cancer diagnostic, Cu-SAR-bisPSMA. The company also expanded its pipeline with promising preclinical data on a pan-cancer agent and secured a key copper-67 supply agreement to support future commercialisation.